4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-035702
Chief Medical Officer sold 6,250 shares at an average $39.67 ($247,968)
- Chief Medical Officer acquired 6,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BALDO LANCE Chief Medical Officer | 2020-06-08 | Option exercise | +2,083 | $7.80 | $16,247 | 2,083 | D |
| BALDO LANCE Chief Medical Officer | 2020-06-08 | Sale | −120 | $39.59 | $4,751 | 1,963 | D |
| BALDO LANCE Chief Medical Officer | 2020-06-08 | Sale | −1,963 | $38.99 | $76,537 | 0 | D |
| BALDO LANCE Chief Medical Officer | 2020-06-09 | Option exercise | +4,167 | $7.80 | $32,503 | 4,167 | D |
| BALDO LANCE Chief Medical Officer | 2020-06-09 | Sale | −4,167 | $40.00 | $166,680 | 0 | D |
| Derivatives | |||||||
| BALDO LANCE Chief Medical Officer | 2020-06-08 | Option exercise · Stock Option (Right to Buy) | −2,083 | 447,917 | D | ||
| BALDO LANCE Chief Medical Officer | 2020-06-09 | Option exercise · Stock Option (Right to Buy) | −4,167 | 443,750 | D | ||
| Open-market sales · 6,250 sh · avg $39.67 · $247,968 | |||||||
Loading xslF345X03/doc4.xml…